Form D · Other
Matrix Genetics, LLC
Seattle, WA · CIK 0001660263
Offering snapshot reported Dec 16, 2015 · SEC filing
- Reported sold
- $1.6M Offering amount: $1.6M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $200K Reported outside-investor minimum
- First sale
- Dec 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 16, 2015 | Initial | $1,600,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-253180
Source: Form D, filed Dec 16, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Simon Best | Director |
| J. Kumar | Director |
| Margaret Mc Cormick | Director, Executive |
| James Roberts | Executive |
| Carl Weissman | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1600 Fairview Avenue E., Suite 300
Seattle, WA, 98102
Seattle, WA, 98102